These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15479822)

  • 1. Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype.
    Karlsson I; Antonsson L; Shi Y; Oberg M; Karlsson A; Albert J; Olde B; Owman C; Jansson M; Fenyö EM
    J Virol; 2004 Nov; 78(21):11807-15. PubMed ID: 15479822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children.
    Cavarelli M; Karlsson I; Zanchetta M; Antonsson L; Plebani A; Giaquinto C; Fenyö EM; De Rossi A; Scarlatti G
    PLoS One; 2008 Sep; 3(9):e3292. PubMed ID: 18820725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors.
    Pontow S; Ratner L
    J Virol; 2001 Dec; 75(23):11503-14. PubMed ID: 11689632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.
    Karlsson U; Antonsson L; Repits J; Medstrand P; Owman C; Kidd-Ljunggren K; Hagberg L; Svennerholm B; Jansson M; Gisslén M; Ljungberg B
    AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1297-1305. PubMed ID: 20001314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.
    Kawamura T; Bruse SE; Abraha A; Sugaya M; Hartley O; Offord RE; Arts EJ; Zimmerman PA; Blauvelt A
    J Virol; 2004 Jul; 78(14):7602-9. PubMed ID: 15220435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.
    Zhang L; He T; Huang Y; Chen Z; Guo Y; Wu S; Kunstman KJ; Brown RC; Phair JP; Neumann AU; Ho DD; Wolinsky SM
    J Virol; 1998 Nov; 72(11):9307-12. PubMed ID: 9765480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
    Torre VS; Marozsan AJ; Albright JL; Collins KR; Hartley O; Offord RE; Quiñones-Mateu ME; Arts EJ
    J Virol; 2000 May; 74(10):4868-76. PubMed ID: 10775626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
    Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
    J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS.
    Jansson M; Backström E; Björndal A; Holmberg V; Rossi P; Fenyö EM; Popovic M; Albert J; Wigzell H
    J Hum Virol; 1999; 2(6):325-38. PubMed ID: 10774549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
    Karlsson I; Antonsson L; Shi Y; Karlsson A; Albert J; Leitner T; Olde B; Owman C; Fenyö EM
    AIDS; 2003 Dec; 17(18):2561-9. PubMed ID: 14685050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency.
    Repits J; Öberg M; Esbjörnsson J; Medstrand P; Karlsson A; Albert J; Fenyö EM; Jansson M
    J Gen Virol; 2005 Oct; 86(Pt 10):2859-2869. PubMed ID: 16186242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates.
    Albright AV; Shieh JT; Itoh T; Lee B; Pleasure D; O'Connor MJ; Doms RW; González-Scarano F
    J Virol; 1999 Jan; 73(1):205-13. PubMed ID: 9847323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
    J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6.
    Grivel JC; Ito Y; Fagà G; Santoro F; Shaheen F; Malnati MS; Fitzgerald W; Lusso P; Margolis L
    Nat Med; 2001 Nov; 7(11):1232-5. PubMed ID: 11689888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV type 1 chemokine receptor usage in mother-to-child transmission.
    Salvatori F; Scarlatti G
    AIDS Res Hum Retroviruses; 2001 Jul; 17(10):925-35. PubMed ID: 11461678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.
    Marozsan AJ; Torre VS; Johnson M; Ball SC; Cross JV; Templeton DJ; Quiñones-Mateu ME; Offord RE; Arts EJ
    J Virol; 2001 Sep; 75(18):8624-38. PubMed ID: 11507208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome.
    Gray L; Sterjovski J; Churchill M; Ellery P; Nasr N; Lewin SR; Crowe SM; Wesselingh SL; Cunningham AL; Gorry PR
    Virology; 2005 Jul; 337(2):384-98. PubMed ID: 15916792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
    Chen Z; Gettie A; Ho DD; Marx PA
    Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.